Cancer Stem Cell Model in Oral Squamous Cell Carcinoma
Journal:
Current Stem Cell Research & Therapy
Volume:
3
Page:
17-20
Author(s):
Zeng-Tong Zhou and Wei-Wen Jiang
Breast Cancer, a Stem Cell Disease
Journal:
Current Stem Cell Research & Therapy
Volume:
3
Page:
55-65
Author(s):
Jesus Perez-Losada and Rogelio Gonzalez-Sarmiento
Inhibitors of Chronically Active Ras: Potential for Treatment of Human Malignancies
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
3
Page:
31-47
Author(s):
Yoel Kloog, Roy Blum and Adrienne D. Cox
Liposomal Formulation for Dermal and Transdermal Drug Delivery: Past, Present and Future
Journal:
Recent Patents on Drug Delivery & Formulation
Volume:
2
Page:
9-18
Author(s):
Mohamed I. Nounou, Labiba K. El-Khordagui, Nawal A. Khalafallah and Said A. Khalil
Modulation of Angiogenesis for Cancer Prevention: Strategies Based On Antioxidants and Copper Deficiency
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3584-3590
Author(s):
Gazala N. Khan and Sofia D. Merajver
Photosensitizer Nanoparticles for Photodynamic Therapy
Journal:
Current Bioactive Compounds
Volume:
3
Page:
239-251
Author(s):
Toru Oba
Beneficial Action of Citrus Flavonoids on Multiple Cancer-Related Biological Pathways
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
795-809
Author(s):
A. Ortuno, O. Benavente-Garcia, J. Castillo, M. Alcaraz, V. Vicente and J. A. Del Rio
Actions of Melatonin, Its Structural and Functional Analogs in the Central Nervous System and the Significance of Metabolism
Journal:
Central Nervous System Agents in Medicinal Chemistry
Volume:
7
Page:
289-303
Author(s):
Rudiger Hardeland and Burkhard Poeggeler
Innate and Adaptive Immune Responses in Allergic Contact Dermatitis and Autoimmune Skin Diseases
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
6
Page:
236-244
Author(s):
Stefan F. Martin, Fanny Edele, Philipp R. Esser, Christian Lass, Melanie N. Laszczyk, Eva Oswald, Christian M. Struh and Anne Rensing-Ehl
Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?
Journal:
Current Pharmacogenomics
Volume:
5
Page:
280-291
Author(s):
Bernard Friedenson